| | | |
| | Age, mean (sd) | 58.07 (1.4) | | Male, % | 46 (51.7%) | | Black, % | 67 (75.3%) | | History of HTN, % | 71 (79.8%) | | Antihypertensive medications, % | 44 (49.4%) | | On antithrombotics (AP/AC), % | 32 (36%) | | History of chronic daily alcohol use, % | 23 (25.8%) | | Positive urine tox screen, % | 17 (19.1%) | | ICH score on admission, median | 1 (0–3) | | Presenting GCS, median | 14 (4–15) | | First SBP, mean (sd) | 189.7 (3.7) | | First DBP, mean (sd) | 111.2 (2.6) | | Baseline NIHSS, median (range) | 15 (0–40) | | Glucose on admission, mean (sd) | 144.65 (6.7) | | ICH location | | | Basal ganglia | 41 (46.1%) | | Thalamus | 18 (20.2%) | | Pons | 5 (5.6%) | | Cerebellum | 5 (5.6%) | | Lobar | 18 (20.2%) | | Other | 1 (1.1%) | | ICH tentorial location | | | Supratentorial | 77 (86.5%) | | Infratentorial | 11 (12.4%) | | Total | 88 (98.9%) | | IVH, % | 42 (47.2%) | | Hydrocephalus, % | 35 (39.3%) | | Edema on initial HCT, % | 62 (69.7%) | | Spot sign on CTA, % | 10 (11.2%) | | Dot sign present on CTA, % | 16 (18%) | | New IVH, % | 6 (6.7%) | | ICH expansion, % | 42 (47.2%) | | Evacuation, % | 12 (13.5%) | | EVD placed, % | 28 (31.5%) | | Did patient receive vitamin k? % | 10 (11.2%) | | Did patient receive FFP? % | 14 (15.7%) | | Did patient receive platelets? % | 17 (19.1%) | | Did patient receive NOVO7? % | 4 (4.5%) | | IVtPA, % | 5 (5.6%) | | In-hospital infection, % | 33 (37.1%) | | In-hospital DVT, % | 2 (2.2%) | | In-hospital UTI, % | 24 (27%) | | In-hospital bacteremia, % | 12 (13.5%) | | Best 24 hr GCS, median | 13 (3–15) | | Follow-up volume, median (range) | 12.3 (0–402) | | 24-hour ICH score, median | 1.0 (0–5) | | Transfer patient, % | 8 (9%) | | Initial shift on HCT, median (range) | 2.0 (0–17) | | ICH initial volume, median (range) | 12.8 (0–186) | | ICH volume 24 hrs, median (range) | 11 (0–402) | | ICH volume growth in 24 hrs, median (range) | 0 (−107–346) | | Length of stay, median (range) | 10 (2–86) | | mRS on discharge, median (range) | 4 (1–6) | | Death, % | 14 (15.7%) |
|
|
